TY - JOUR T1 - Investigating the genetic pathways of insomnia in Autism Spectrum Disorder JF - medRxiv DO - 10.1101/2022.02.03.22270340 SP - 2022.02.03.22270340 AU - Maria Niarchou AU - Emily V. Singer AU - Peter Straub AU - Beth A. Malow AU - Lea K. Davis Y1 - 2022/01/01 UR - http://medrxiv.org/content/early/2022/02/04/2022.02.03.22270340.abstract N2 - Background Sleep problems are common in children with autism spectrum disorder (autism). There is sparse research to date to examine whether insomnia in people with autism is related to autism genetics or insomnia genetics. Moreover, there is a lack of research examining whether circadian-rhythm related genes share potential pathways with autism.Aims To address this research gap, we tested whether polygenic scores of insomnia or autism are related to risk of insomnia in people with autism, and to test whether the circadian genes are associated with insomnia in people with autism.Methods and procedures We tested these questions using the phenotypically and genotypically rich MSSNG dataset (N=1,049) as well as incorporating in the analyses data from the Vanderbilt University Biobank (BioVU) (N=349).Outcomes and results In our meta-analyzed sample, there was no evidence of associations between the polygenic scores (PGS) for insomnia and a clinical diagnosis of insomnia, or between the PGS of autism and insomnia. We also did not find evidence of a greater burden of rare and disruptive variation in the melatonin and circadian genes in individuals with autism and insomnia compared to individuals with autism without insomnia.Conclusions and implications Overall, we did not find evidence for strong effects of genetic scores influencing sleep in people with autism, however, we cannot rule out the possibility that smaller genetic effects may play a role in sleep problems. Our study indicated the need for a larger collection of data on sleep problems and sleep quality among people with autism.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe study was funded by Autism Speaks (#11680)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The project was approved by the Vanderbilt University Medical Center (VUMC) Institutional Review Board (IRB #190564).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesRegarding the BioVU sample, due to data sharing restrictions related to privacy concerns in the EHR, the datasets generated from our hospital population will not be publicly available. Regarding the MSSNG sample, data are available in the MSSNG repository (http://research.mss.ng) ER -